Observational studyIndian heart journal

Observational study to evaluate the safety and efficacy of saroglitazar in Indian diabetic dyslipidemia patients.

Sadanand R Shetty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.